![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Baebies’ Genetic Screening Assay Receives CE Mark
Baebies’ Genetic Screening Assay Receives CE Mark
![CE mark](https://www.fdanews.com/ext/resources/images/ce-mark.gif?t=1627682539&width=430)
Newborn screening and pediatric test developer Baebies has received a CE mark for assays that screen for two genetic disorders.
The galactosemia and biotinidase deficiency assays, which run on the company’s Seeker screening platform, use dried blood-spot specimens to detect reduced enzyme activity in newborns.
The Durham, N.C.-based company is launching the assays in Europe and other countries that recognize the CE mark.
Upcoming Events
-
21Oct